Development of immune invisible beta cells as a cell therapy for type 1 diabetes through genetic modification of hESCs

  • Post author:
  • Post category:

Research Objective Development of hESC-derived pancreatic beta cells that are protected from allogeneic and autoimmune attack into a cell therapy for type 1 diabetes (T1D) Impact Cell therapy of T1D…

Continue ReadingDevelopment of immune invisible beta cells as a cell therapy for type 1 diabetes through genetic modification of hESCs